Sutro Biopharma Non-Current Deferred Liabilities (Quarterly) Analysis

Sutro Biopharma, Inc. (STRO)

10.84 +0.20 (+1.93%) USD | NASDAQ | Jan 14, 10:20

View Non-Current Deferred Liabilities (Quarterly) for STRO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Liabilities (Quarterly) Benchmarks

Start Trial

GT Biopharma, Inc.	--
Daré Bioscience, Inc.	Upgrade
Syndax Pharmaceuticals, Inc.	--
Crinetics Pharmaceuticals, Inc.	Upgrade
NovaBay Pharmaceuticals, Inc.	--